 ofloxacin parenter therapi chronic osteomyel random comparison oral ofloxacin mg day parenter agent cefazolin ceftazidim biopsy-confirm nonprosthesi osteomyel total subject averag week parenter antibiot averag week therapi infect due staphylococcu aureu enterococcu spp pseudomona aeruginosa gram-neg organ complet therapi aeruginosa infect ofloxacin group organ resist resist acinetobact superinfect parenter group aureu infect resolv superinfect due aureu eighteen-month follow-up data ofloxacin subject initi respons therapi success suffer relaps infect due aureu due aeruginosa parenter group subject aeruginosa infect long-term respons therapi success subject ofloxacin parenter antibiot differ signific oral ofloxacin compar parenter antibiot chronic osteomyel due suscept organ oral ofloxacin offer advantag econom conveni